Safety of cefepime: A new extended-spectrum parenteral cephalosporin
Open Access
- 24 June 1996
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (6) , 68S-75S
- https://doi.org/10.1016/s0002-9343(96)00110-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and childrenAntimicrobial Agents and Chemotherapy, 1995
- Randomized Comparison of Cefepime and Ceftazidime for Treatment of Hospitalized Patients with Gram-Negative BacteremiaClinical Infectious Diseases, 1995
- Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndromeAntimicrobial Agents and Chemotherapy, 1994
- Open trial of cefepime (BMY 28142) for infections in hospitalized patientsAntimicrobial Agents and Chemotherapy, 1990
- Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous dosesAntimicrobial Agents and Chemotherapy, 1990
- Third Generation Cephalosporins: Safety Profiles After 10 Years of Clinical UseThe Journal of Clinical Pharmacology, 1990
- The use of cefepime (BMY 28142) to treat respiratory infectionsDiagnostic Microbiology and Infectious Disease, 1989
- Side Effects of CephalosporinsDrugs, 1987
- Inhibition of Granulopoiesis in Vivo and in Vitro by -Lactam AntibioticsThe Journal of Infectious Diseases, 1985
- Safety of Cefoxitin: An Approach to the Analysis of Laboratory DataClinical Infectious Diseases, 1979